{
  "title": "Determine whether differences in TLR-responsiveness alter susceptibility to Biodefense priority pathogens using WN virus as a paradigm or responsiveness to vaccination using influenza as a model shared to Semi-Public Workspace (SPW) Project",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY41",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Determine whether differences in TLR-responsiveness alter susceptibility to Biodefense priority pathogens using WN virus as a paradigm or responsiveness to vaccination using influenza as a model shared to Semi-Public Workspace (SPW) Project",
  "performedBy": [
    {
      "firstName": "Erol",
      "lastName": "Fikrig ",
      "email": "?",
      "affiliations": [
          {
             "name": "Yale School of Medicine"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "firstName": "Norma",
      "lastName": "Andrews",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Jorge",
      "lastName": "Galan",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "John",
      "lastName": "MacMicking",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Craig",
      "lastName": "Roy",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Young Adults",
          "size": 367
        },
        {
          "name": "Elderly",
          "size": 372
        },
        {
          "name": "Immunocompromised",
          "size": 145
        },
        {
          "name": "WNV Infected",
          "size": 19
        }
  ],
  
  "usesReagent": [
        {
          "name": "VeriKine Human Interferon-Alpha ELISA Kit"
        },
        {
          "name": "VeriKine Human Interferon-Beta ELISA Kit"
        },
        {
          "name": "BD OptEIA Human IL-10 ELISA Set"
        },
        {
          "name": "BD OptEIA Human IL-12 (p70) ELISA Set"
        },
        {
          "name": "beta Actin Fwd Primers"
        },
        {
          "name": "beta Actin Rev Primers"
        },
        {
          "name": "beta Actin Probe"
        },
        {
          "name": "TLR3 F Primers"
        },
        {
          "name": "TLR3 R Primers"
        },
        {
          "name": "TLR3 Probe"
        },
        {
          "name": "TLR7 Fwd Primers"
        },
        {
          "name": "TLR7 Rev Primers"
        },
        {
          "name": "TLR7 Probe"
        },
        {
          "name": "DDX58, Hs00204833_m1 "
        },
        {
          "name": "IFN-beta Fwd Primers"
        },
        {
          "name": "IFN-beta Rev Primers"
        },
        {
          "name": "IFN-beta Probe"
        },
        {
          "name": "CXCL10, Hs00171042_m1"
        },
        {
          "name": "WNV E Fwd Primers"
        },
        {
          "name": "WNV E Rev Primers"
        },
        {
          "name": "WNV E Probe"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Ambulatory older subjects who are not nursing home residents"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects with acute infection (fever and symptoms within 2 weeks of enrollment)"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Taking 10mg or more of  Prednisone daily for at least one month"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Have illnesses such polymyalgia rheumatica, rheumatoid arthritis, and systemic lupus erythematosus, and at least for the latter two illnesses"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Taking other drugs considered in immunosuppression in addition to Prednisone such as plaquenil, sulfasalzine, methotrexate, immuran, cytoxan, tacrolimus, mycophenolate mofetil, other chemotherapeutic agents and other  chemotherapeutic agents"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Organ transplantation subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Malignancy other than localized skin cancer subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Nonmetastatic  prostate cancer subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Asplenia subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Dysglobulinemia subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Cirrhosis subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Renal failure requiring hemodialysis"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "All genders and ethnic groups"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects with a history of previous adverse reaction to influenza vaccine (rash, anaphylaxis)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Guillain-Barre syndrome"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Allergy to eggs "
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Erol",
      "lastName": "Fikrig ",
      "email": "?",
      "affiliations": [
          {
             "name": "Yale School of Medicine"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Innate Immune Responsiveness in the Elderly and the Immunosuppressed",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "N01-AI-050031"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "This proposal will explore the hypothesis that altered innate immune responses in the elderly and the immunosuppressed contribute to vaccine unresponsiveness and disease susceptibility.  We will first (Aim 1) assess the levels of TLR expression and the efficiency of TLR responsiveness in younger adults versus elderly or immunosuppressed populations. In addition, we will assess the effect of aging on macrophage migration inhibitory factor (MIF), a TLR-responsive mediator that critically regulates monocyte/macrophage activation responses and downstream cytokine production.  We will then (Aim 2) assess the effects of these impairments in innate immunity, identified in Aim 1, on the efficiency of the response to Biodefense priority pathogens, using West Nile virus infection and influenza vaccination as models. These studies will lead to a greater understanding of how alterations in innate immune responses in high-risk populations such as in the elderly and the immunosuppressed contribute to disease susceptibility and vaccine responsiveness.  Understanding of these mechanisms of impaired host defense will be of general benefit, particularly given the potential for the emergence of new pathogens or outbreaks (including the widened range of mosquito vectors harboring West Nile virus in the United States) or the engineering of virulent or drug resistant agents for bioterorrism.  http://projectreporter.nih.gov/project_info_details.cfm?aid=7337892&icde=23814545&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "17202359",
          "identifierSource": "pubmed"
        },
      "authorsList": "van Duin D(1), Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, Allore HG, Medzhitov R, Shaw AC.",
      "title": "Age-associated defect in human TLR-1/2 function.",
      "publicationVenue": "J Immunol.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "17471428",
          "identifierSource": "pubmed"
        },
      "authorsList": "van Duin D(1), Allore HG, Mohanty S, Ginter S, Newman FK, Belshe RB, Medzhitov R, Shaw AC.",
      "title": "Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "17767688",
          "identifierSource": "pubmed"
        },
      "authorsList": "van Duin D(1), Shaw AC.",
      "title": "Toll-like receptors in older adults.",
      "publicationVenue": "J Am Geriatr Soc.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "17909632",
          "identifierSource": "pubmed"
        },
      "authorsList": "Arjona A(1), Foellmer HG, Town T, Leng L, McDonald C, Wang T, Wong SJ, Montgomery RR, Fikrig E, Bucala R.",
      "title": "Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.",
      "publicationVenue": "J Clin Invest.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18056386",
          "identifierSource": "pubmed"
        },
      "authorsList": "Arjona A(1), Ledizet M, Anthony K, Bonaf?, Modis Y, Town T, Fikrig E.",
      "title": "West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.",
      "publicationVenue": "J Immunol.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18256150",
          "identifierSource": "pubmed"
        },
      "authorsList": "Dai J(1), Wang P, Bai F, Town T, Fikrig E.",
      "title": "Icam-1 participates in the entry of west nile virus into the central nervous system.",
      "publicationVenue": "J Virol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18355125",
          "identifierSource": "pubmed"
        },
      "authorsList": "Kong KF(1), Wang X, Anderson JF, Fikrig E, Montgomery RR.",
      "title": "West nile virus attenuates activation of primary human macrophages.",
      "publicationVenue": "Viral Immunol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18508883",
          "identifierSource": "pubmed"
        },
      "authorsList": "Kong KF(1), Delroux K, Wang X, Qian F, Arjona A, Malawista SE, Fikrig E, Montgomery RR.",
      "title": "Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly.",
      "publicationVenue": "J Virol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18632868",
          "identifierSource": "pubmed"
        },
      "authorsList": "Wang P(1), Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, Madri JA, Fikrig E.",
      "title": "Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.",
      "publicationVenue": "J Virol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18690214",
          "identifierSource": "pubmed"
        },
      "authorsList": "Krishnan MN(1), Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ,  Xavier RJ, Agaisse H, Fikrig E.",
      "title": "RNA interference screen for human genes associated with West Nile virus infection.",
      "publicationVenue": "Nature.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19200759",
          "identifierSource": "pubmed"
        },
      "authorsList": "Town T(1), Bai F, Wang T, Kaplan AT, Qian F, Montgomery RR, Anderson JF, Flavell  RA, Fikrig E.",
      "title": "Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing.",
      "publicationVenue": "Immunity.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19346297",
          "identifierSource": "pubmed"
        },
      "authorsList": "Yende S(1), Angus DC, Kong L, Kellum JA, Weissfeld L, Ferrell R, Finegold D, Carter M, Leng L, Peng ZY, Bucala R.",
      "title": "The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.",
      "publicationVenue": "FASEB J.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19541535",
          "identifierSource": "pubmed"
        },
      "authorsList": "Panda A(1), Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC.",
      "title": "Human innate immunosenescence: causes and consequences for immunity in old age.",
      "publicationVenue": "Trends Immunol.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19816558",
          "identifierSource": "pubmed"
        },
      "authorsList": "Bai F(1), Town T, Qian F, Wang P, Kamanaka M, Connolly TM, Gate D, Montgomery RR, Flavell RA, Fikrig E.",
      "title": "IL-10 signaling blockade controls murine West Nile virus infection.",
      "publicationVenue": "PLoS Pathog.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20100933",
          "identifierSource": "pubmed"
        },
      "authorsList": "Panda A(1), Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC.",
      "title": "Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.",
      "publicationVenue": "J Immunol.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20404807",
          "identifierSource": "pubmed"
        },
      "authorsList": "Mathai SK(1), Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN, Murray LA, Siner JM, Antin-Ozerkis DE, Montgomery RR, Reilkoff RA, Bucala RJ, Herzog EL.",
      "title": "Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.",
      "publicationVenue": "Lab Invest.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20596538",
          "identifierSource": "pubmed"
        },
      "authorsList": "Dunne DW(1), Shaw A, Bockenstedt LK, Allore HG, Chen S, Malawista SE, Leng L, Mizue Y, Piecychna M, Zhang L, Towle V, Bucala R, Montgomery RR, Fikrig E.",
      "title": "Increased TLR4 expression and downstream cytokine production in immunosuppressed  adults compared to non-immunosuppressed adults.",
      "publicationVenue": "PLoS One.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20667703",
          "identifierSource": "pubmed"
        },
      "authorsList": "Shaw AC(1), Joshi S, Greenwood H, Panda A, Lord JM.",
      "title": "Aging of the innate immune system.",
      "publicationVenue": "Curr Opin Immunol.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20818395",
          "identifierSource": "pubmed"
        },
      "authorsList": "Wang P(1), Arjona A, Zhang Y, Sultana H, Dai J, Yang L, LeBlanc PM, Doiron K, Saleh M, Fikrig E.",
      "title": "Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I.",
      "publicationVenue": "Nat Immunol.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "21050124",
          "identifierSource": "pubmed"
        },
      "authorsList": "Bai F(1), Kong KF, Dai J, Qian F, Zhang L, Brown CR, Fikrig E, Montgomery RR.",
      "title": "A paradoxical role for neutrophils in the pathogenesis of West Nile virus.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "21398396",
          "identifierSource": "pubmed"
        },
      "authorsList": "Qian F(1), Wang X, Zhang L, Lin A, Zhao H, Fikrig E, Montgomery RR.",
      "title": "Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2011",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "22023165",
          "identifierSource": "pubmed"
        },
      "authorsList": "Qian F(1), Wang X, Zhang L, Chen S, Piecychna M, Allore H, Bockenstedt L, Malawista S, Bucala R, Shaw AC, Fikrig E, Montgomery RR.",
      "title": "Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly.",
      "publicationVenue": "Aging Cell.",
      "dates": [
        {
          "date": "2012",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Observational"
      },
      {
        "value": "Infection Response"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2013-06-12",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "Stimulate human DCs with live WNV and quantify IFN-alpha, IFN-beta, IL10 and IL12 production by ELISA",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "Stimulate human DCs with live WNV and quantify cytokine (IFN-b and CXCL10) production by Q-PCR",
        "types": [
            {
               "value": "Q-PCR"
            }
        ]
      },{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "Using live West Nile virus (strain WN 2741), quantify the uptake of WNV in vitro by human DC from the two subject groups. Viral load will be quantified by Q-PCR of WNV E protein from infected human DC cell lysates",
        "types": [
            {
               "value": "Q-PCR"
            }
        ]
      },{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "Examine mRNA expression of TLRs by Q-PCR in unstimulated and WNV-stimulated DCs",
        "types": [
            {
               "value": "Array"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "WNv infection 0 hours"
        },
        {
          "name": "WNv infection 24 hours"
        },
        {
          "name": "WNv infection 48 hours"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY41",
              "identifierSource": "ImmPort"
          },
          "title": "Determine whether differences in TLR-responsiveness alter susceptibility to Biodefense priority pathogens using WN virus as a paradigm or responsiveness to vaccination using influenza as a model shared to Semi-Public Workspace (SPW) Project",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY41",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Innate Immune Responsiveness in the Elderly and the Immunosuppressed",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "None"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "To assess the effects of the impairments in innate immunity identified in the study titled <i><u>Delineate innate immune responses in populations at risk (the elderly and the immunosuppressed) that are different from the general population</u></i> on the efficiency of the response to agents of Bioterrorism, using WN virus infection and influenza vaccination as models.<br/><br/>Will also assess these responses directly from patients who had WN virus infection or the influenza vaccine.  Will elucidate mechanisms mediating innate immune responses to viral infection using murine models."
}
